United Kingdom· GB-APID-10677611000001100
Prochlorperazine 12.5mg/1ml solution for injection ampoules
A prochlorperazine product containing prochlorperazine, registered in United Kingdom by Advanz Pharma. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Prochlorperazine is registered in 8 of 19 countries.
Countries holding a registration under ATC N05AB04 (prochlorperazine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Prochlorperazine · ATC N05AB04
8 / 19 countries
- Canada
- Finlandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Prochlorperazine
- Manufacturer
- Advanz Pharma
- Country
- United Kingdom (GB)
- ATC code
- N05AB04
- ATC class
- Prochlorperazine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5099602334281
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
494 interactions on record for prochlorperazine.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prochlorperazine · interactions on record
494 records
- 45 severe
- 279 moderate
- 9 minor
- 161 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prochlorperazine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesComproPD-Rx Pharmaceuticals, Inc.
- FinlandStemetilsanofi-Aventis Oy
- CanadaODAN-PROCHLORPERAZINEODAN LABORATORIES LTD
- NorwayCompro
- IrelandStemetil 5mg TabletsAtnahs Pharma Netherlands B.V.
- PolandChloropernazinumLabor Przedsiębiorstwo Farmaceutyczno-Chemiczne Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Cyprus · Nautisol
- Finland · Stemetil
- Ireland · Stemetil
- Italy · Stemetil
- Norway · Stemetil
- Poland · Chloropernazinum
- Romania · Emetiral, Proclorperazina Sintofarm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfc114e6-e7a9-424d-8737-f7eb5a27f1b2 GET /v1/drugs/bfc114e6-e7a9-424d-8737-f7eb5a27f1b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10677611000001100",
"desc": "Prochlorperazine 12.5mg/1ml solution for injection ampoules (Advanz Pharma)",
"form": "Solution for injection",
"vpid": "36021511000001106",
"source": "dmd",
"vtm_id": "777322002",
"strength": "12.5 mg",
"substance": "Prochlorperazine",
"ingredient": "Prochlorperazine mesilate",
"supplier_code": "24129411000001106"
}See everything about prochlorperazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.